MONTREAL, May 28, 2024 /CNW/ - Amplitude Ventures, a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology and AI, today announced the close of its $263 million (US$192 million) Fund II. The new fund substantially exceeds the size of Amplitude's inaugural fund and enables the firm to continue to invest with entrepreneurs and innovators who are building new precision medicine companies that are driving meaningful outcomes in human health.
Read more at newswire.cahello world
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
